SS&H Financial Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.72M Buy
17,871
+1,500
+9% +$146K 0.5% 52
2025
Q3
$1.56M Buy
16,371
+10,915
+200% +$1M 0.47% 53
2025
Q2
$476K Buy
5,456
+700
+15% +$59.4K 0.16% 92
2025
Q1
$427K Hold
4,756
0.16% 93
2024
Q4
$380K Hold
4,756
0.14% 103
2024
Q3
$428K Hold
4,756
0.16% 100
2024
Q2
$374K Hold
4,756
0.15% 106
2024
Q1
$414K Hold
4,756
0.17% 96
2023
Q4
$392K Buy
4,756
+2,000
+73% +$152K 0.17% 99
2023
Q3
$216K Buy
+2,756
New +$231K 0.1% 114
2022
Q3
Sell
-2,300
Closed -$206K 117
2022
Q2
$206K Sell
2,300
-400
-15% -$40.5K 0.1% 120
2022
Q1
$300K Buy
+2,700
New +$285K 0.12% 120

Other funds holding MDT

SS&H Financial Advisors's MDT Position: Q4 2025 in Review

SS&H Financial Advisors increased its Medtronic (MDT) stake by 9.2% in Q4 2025, buying an estimated $146K and bringing the position to 17,871 shares worth $1.72M. The position accounts for 0.5% of the portfolio, ranked #52.

SS&H Financial Advisors first reported a position in MDT in Q1 2022 and has held it in 12 quarters since. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • SS&H Financial Advisors held 17,871 shares of Medtronic worth $1.72M as of Q4 2025.
  • SS&H Financial Advisors bought 1,500 Medtronic shares in Q4 2025, an estimated $146K.
  • Medtronic made up 0.5% of SS&H Financial Advisors's portfolio in Q4 2025, its #52 holding.
  • SS&H Financial Advisors first reported a position in Medtronic in Q1 2022 and has held it in 12 quarters since.
  • 2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on SS&H Financial Advisors's 13F filing for Q4 2025, filed 20 Jan 2026.